Welcome to our dedicated page for Multiplan Corporation SEC filings (Ticker: MPLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page associated with the historical MPLN ticker provides a gateway into the regulatory record of the company that began as MultiPlan Corporation and now operates as Claritev Corporation. As part of its evolution, the company has rebranded and its Class A common stock is identified in SEC filings as trading on the New York Stock Exchange under the symbol CTEV. Filings refer to Claritev Corporation as a Delaware corporation and describe it as a healthcare technology, data and insights company focused on affordability, transparency and quality in the U.S. healthcare system.
Investors reviewing filings linked from this page can trace how the company communicates its financial condition, transformation initiatives and capital structure. Form 8-K reports referenced in the available data include disclosures about financial results for specific quarters and the release of investor slide presentations, as well as extensive forward-looking statements and risk factor discussions. Other public materials describe a comprehensive refinancing of the company’s debt capital structure through exchange offers and consent solicitations involving senior secured notes, senior notes, convertible notes and term loans.
On Stock Titan, SEC documents for this issuer are paired with AI-powered tools that help interpret complex regulatory language. Users can access current and historical filings such as Form 8-K reports to understand material events, financing transactions and updates on the company’s transformation journey. AI-generated summaries are designed to highlight key points, such as changes in capital structure, guidance commentary and references to strategic plans, while preserving the underlying text for detailed review.
Because the MPLN ticker has transitioned to CTEV, this page is particularly useful for placing newer Claritev filings in historical context. By examining the sequence of disclosures, investors can follow the company’s path from MultiPlan under MPLN to Claritev under CTEV, including its focus on technology, data and AI to support stakeholders across the U.S. healthcare ecosystem.
Claritev Corporation filed a current report to let investors know it is making an updated slide presentation available on its website beginning on September 3, 2025. The presentation, attached as Exhibit 99.1, is meant to share information under Regulation FD, which is designed to ensure all investors receive material company information at the same time.
The company states that the slide deck and the related disclosure are being "furnished" rather than "filed," meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.
White Dale A., a director of Claritev Corp (CTEV), reported transactions dated 08/21/2025 that moved 201,652 shares of Class A common stock from direct ownership into a revocable trust. The Form 4 shows a Code G transfer with a reported price of $0, indicating an internal transfer rather than a market sale. After the transfer the reporting person is shown with 160,080 shares held directly and 201,652 shares held indirectly by trust. The filing is signed by an attorney-in-fact on 08/25/2025.
Claritev Corp (CTEV) reporting person Dalton Travis, who is President, CEO & Executive Chair and a director, reported purchases of Class A common stock totaling 4,282 shares. The Form 4 shows a purchase of 300 shares on 08/08/2025 at a weighted average price of $54.2083 (individual trades ranged $54.18–$54.25) and a purchase of 3,982 shares on 08/11/2025 at a weighted average price of $58.3019 (individual trades ranged $58.06–$58.50). The shares are reported as indirectly beneficially owned in the reporting person’s spouse’s Individual Retirement Account, bringing indirect holdings to 4,282 shares. The Form 4 was executed by attorney-in-fact Kent Bartholomew and dated 08/12/2025.
Claritev Corporation reported that its Executive Vice President and Chief Operating Officer, Jerome Hogge, purchased 5,621 shares of Class A common stock on 08/07/2025 at a weighted average price of $53.5084 (individual trades ranged from $53.26 to $53.56). Following these purchases, Hogge's beneficial ownership increased to 90,023 shares.
The Form 4 notes the price shown is a weighted average for multiple transactions and that the reporting person will provide full breakdowns of the number of shares purchased at each price upon request. No derivative transactions are reported on this form.